Floatz logo

Promethazine

NK/T Cell Lymphoma

PersonGen BioTherapeutics (Suzhou) Co., Ltd.Small moleculePhase 1Dormant
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

3 Active assets in the NK/T Cell Lymphoma cohort.

Asset / SponsorPhaseRating
CIS-DIAMMINEDICHLOROPLATINUM II
National Cancer Centre, Singapore
Phase 4BBB
Nivolumab
National Cancer Centre, Singapore
Phase 2B
5-azacytidine
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Phase 2CCC
Gnc-038
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 1/2CCC
ASPARAGINASE
National Cancer Centre, Singapore
Phase 1CC
cd19-ucart
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Phase 1CC
Anti Cd30 Car-T Cell
Zhejiang University
Early Phase 1C

Same molecule, other indications

Promethazine is also rated in:

disruptive behavior disorderDormant
BB
Indicative ·
64 / 100
View asset →
migraine without auraDormant
B
Indicative ·
62 / 100
View asset →
physiological malfunction arising from mental factorDormant
B
Indicative ·
60 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →